Font Size: a A A
Keyword [relapsed and refractory]
Result: 1 - 20 | Page: 1 of 2
1. The Clinical Research On The Efficacy Of GDP Regimen On Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma
2. Primary Investigation Of ProMACE-CytaBOM Modified Regimen In Treating Relapsed Or Refractory Aggressive NHL
3. Arsenic Trioxide Combination Chemotherapy In The Treatment Of Relapsed And Refractory Peripheral T-cell Lymphoma Efficacy Analysis
4. Parental Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation In Treatment Of Children With Relapsed And Refractory Acute Leukemia
5. The Application Of DNA Methylationin Acute Myeloid Leukemia And Myelodysplasticsyndrome
6. A Primary Clinical Study Of Sorafenib Combined With Low Dose Cytarabine On FLT3~+ Relapsed And Refractory Acute Myeloid Leukemia
7. An Analysis Of Prognosis Factors And Re-induction Therapy Outcomes For Patients With Relapsed And Refractory Acute Myeloid Leukemia
8. Related Haploidentical Peripheral Blood Stem Cell Transplantation For Treatment Of Refractory And Relapsed Acute Leukemia
9. The Expression And Correlation Research Of MDSC,T-lymphocyte Subsets And Cytokines In Relapsed And Refractory Immune Thrombocytopenia Treated By High Dose Of Vitamin C,Rituximab And Glucocorticoid
10. Chronic Lymphocytic Leukemia And Autoimmune Hemolytic Leukemia Treatment Of Relapsed And Refractory Chronic Lymphocytic Leukemia With Ibrutinib
11. The Clinical Observations Of Lenalidomine Plus Dexamethasone For Relapsed And Refractory Multiple Myeloma
12. Treatment Of Relapsed And Refractory Acute Myeloid Leukemia (MDs Transformation) With CD123 Chimeric Antigen Receptor T Cell And Literature Review
13. Study On Safety,Efficacy And Intestinal Microecology Of BCMA CAR-T Cells In The Treatment Of Relapsed And Refractory Multiple Myeloma
14. Analysis Of Clinical Efficacy Of Different Chemotherapy Regimen Containing Etoposide In The Treatment Of Relapsed And Refractory Acute Myeloid Leukemia
15. Meta Analysis Of The Efficacy And Safety Of Monoclonal Antibody-based Three-drug Regimens For Relapsed And Refractory Multiple Myeloma
16. Clinical Efficacy And Safety Analysis Of Apatinib In The Treatment Of Relapsed And Refractory Diffuse Large B-cell Lymphoma
17. Efficacy And Safety Of CD19 CAR T Cells In The Treatment Of Relapsed And Refractory Acute B Lymphocytic Leukemia With Central Nervous System Invasion
18. Study On Prognosis-related Alternative Splicing Events Of Acute Myeloid Leukemia And Cell Biological Function Of BCL2L11-γ Spliceosome
19. Clinical Analysis Of BCMA CAR-T Cells In The Treatment Of Relapsed And Refractory Multiple Myeloma Patients
20. Clinical Study Of CLAG And FLAG Regimens In The Treatment Of Relapsed And Refractory Acute Myeloid Leukemia
  <<First  <Prev  Next>  Last>>  Jump to